| 000 | 00850 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250517042504.0 | ||
| 264 | 0 | _c20160202 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a1097-0142 | ||
| 024 | 7 |
_a10.1002/cncr.29424 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOwonikoko, Taofeek K | |
| 245 | 0 | 0 |
_aInhibitors of mTOR pathway for cancer therapy, moving on from rapalogs to TORKinibs. _h[electronic resource] |
| 260 |
_bCancer _cOct 2015 |
||
| 300 |
_a3390-2 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Research Support, N.I.H., Extramural; Comment | ||
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacokinetics |
| 773 | 0 |
_tCancer _gvol. 121 _gno. 19 _gp. 3390-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cncr.29424 _zAvailable from publisher's website |
| 999 |
_c25077227 _d25077227 |
||